Skip to main content
. 2007 Nov 7;46(1):109–117. doi: 10.1128/JCM.01667-07

TABLE 6.

Two-year cumulative absolute risk of histologically confirmed CIN3 or worsea

Parameter n QC pathology
CC pathology
Worst pathology
No. CIN3 or more % CIN3 or more No. CIN3 or more % CIN3 or more No. CIN3 or more % CIN3 or more
LA
    Negative 1,041 11 1.1 2 0.2 12 1.2
    Noncarcinogenic 450 11 2.4 6 1.3 13 2.9
    Carcinogenic 1,120 86 7.7 79 7.1 110 9.8
    HPV18 162 14 8.6 10 6.2 17 10.5
    HPV16 562 165 29.4 141 25.1 182 32.4
LBA
    Negative 1,281 24 1.9 9 0.7 27 2.1
    Noncarcinogenic 402 13 3.2 8 2.0 15 3.7
    Carcinogenic 1,028 81 7.9 78 7.6 105 10.2
    HPV18 129 11 8.5 8 6.2 13 10.1
    HPV16 495 158 31.9 135 27.3 174 35.2
Total 3,335 287 8.6 238 7.1 334 10.0
a

As diagnosed by QC pathology, clinical-center pathologists (CC pathology), or either pathology review (Worst pathology) for detection of HPV categorized as HPV risk groups by LA or by LBA.